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Desmosome Disassembly in Response to Pemphigus
Vulgaris IgG Occurs in Distinct Phases and Can Be
Reversed by Expression of Exogenous Dsg3
Jean M. Jennings1,4, Dana K. Tucker1,4, Margaret D. Kottke1, Masataka Saito1, Emmanuella Delva1,
Yasushi Hanakawa2, Masayuki Amagai3 and Andrew P. Kowalczyk1
Pemphigus vulgaris (PV) is an epidermal blistering disorder caused by antibodies directed against the
desmosomal cadherin desmoglein-3 (Dsg3). The mechanism by which PV IgG disrupts adhesion is not fully
understood. To address this issue, primary human keratinocytes (KCs) and patient IgG were used to define the
morphological, biochemical, and functional changes triggered by PV IgG. Three phases of desmosome
disassembly were distinguished. Analysis of fixed and living KCs demonstrated that PV IgG cause rapid Dsg3
internalization, which likely originates from a non-junctional pool of Dsg3. Subsequently, Dsg3 and other
desmosomal components rearrange into linear arrays that run perpendicular to cell contacts. Dsg3 complexes
localized at the cell surface are transported in a retrograde manner along with these arrays before being
released into cytoplasmic vesicular compartments. These changes in Dsg3 distribution are followed by
depletion of detergent-insoluble Dsg3 pools and by the loss of cell adhesion strength. Importantly, this process
of disassembly can be prevented by expressing exogenous Dsg3, thereby driving Dsg3 biosynthesis and
desmosome assembly. These data support a model in which PV IgG cause the loss of cell adhesion by altering
the dynamics of Dsg3 assembly into desmosomes and the turnover of cell surface pools of Dsg3 through
endocytic pathways.
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INTRODUCTION
Desmosomes are adhesive intercellular junctions that medi-
ate attachment of intermediate filament networks to sites of
cell-to-cell contact (Green and Simpson, 2007; Holthofer
et al., 2007; Desai et al., 2009). Desmosomes are prominent
in tissues that experience substantial mechanical stress,
including the heart and the epidermis (Bazzi and Christiano,
2007). The desmogleins and desmocollins are the major
desmosomal adhesion molecules and are members of the
cadherin gene superfamily (Wheelock and Johnson, 2003;
Garrod and Chidgey, 2008). Adhesive interactions medi-
ated by desmogleins and desmocollins are coupled to the
intermediate filament cytoskeleton by an elaborate arrange-
ment of cytoplasmic proteins. These desmosomal plaque
molecules include the armadillo family proteins plakoglobin
and plakophilins (Hatzfeld, 2007), as well as members of
the plakin cytolinker family, such as desmoplakin (Green and
Simpson, 2007; Sonnenberg and Liem, 2007).
Desmosome function is compromised in a number of
inherited (Bazzi and Christiano, 2007; Lai-Cheong et al.,
2007; Awad et al., 2008) and autoimmune disorders (Stanley
and Amagai, 2006). Pemphigus vulgaris (PV) is an acquired
disease in which the desmosomal cadherin desmoglein-3
(Dsg3) is targeted by autoantibodies (Kottke et al., 2006;
Waschke, 2008). Patients with this disorder exhibit severe oral
erosions as well as epidermal blistering if the disease progresses
to include targeting of Dsg1. Importantly, IgG can be isolated
from PV patient serum and used in mouse and tissue culture
models to investigate the mechanism of disease pathogenesis
(Kottke et al., 2006; Amagai, 2008). For example, injection of
IgG from pemphigus patients into newborn mice causes
epidermal blistering that is indistinguishable from that observed
in patients (Stanley and Amagai, 2006). Similarly, PV IgG
disrupts desmosomes and compromises adhesion strength when
incubated in the media of cultured keratinocytes (KCs; Payne
et al., 2004). This ability to passively transfer the disease from
the patient to various model systems has resulted in significant
advances in our understanding of PV pathobiology. None-
theless, the precise mechanism by which PV IgG causes loss of
KC adhesion is not fully understood.
Evidence from mouse models, as well as atomic force
microscopy, suggests that PV IgG may directly disrupt Dsg3
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trans (adhesive) interactions (Shimizu et al., 2004; Heupel
et al., 2008). Similarly, mapping of pathogenic epitopes from
both patient IgG and experimentally generated monoclonal
antibodies indicate that pathogenic antibodies target the
amino-terminal region of Dsg3, a cadherin domain critical for
adhesive interactions (Tsunoda et al., 2003). These findings
offer compelling evidence that disruption of Dsg3 adhesive
interactions causes the loss of adhesion and blistering that
characterizes the disease in patients. However, other
work suggests a more complicated effect of PV IgG on KCs
(Sharma et al., 2007; Muller et al., 2008; Waschke, 2008).
For example, a number of studies have demonstrated that
pharmacological approaches targeting various signaling
pathways can prevent loss of adhesion both in vitro and
in vivo (Berkowitz et al., 2005, 2006; Williamson et al.,
2006). These studies suggest that PV IgG trigger KC responses
and signal transduction cascades that are required for loss
of adhesion. Similarly, previous work from our laboratory
demonstrated that KC exposure to PV IgG at 4 1C is insuffi-
cient to cause loss of adhesion, even though PV IgG bind
Dsg3 and decorate cell–cell borders (Calkins et al., 2006). In
fact, incubation in PV IgG for several hours is required before
detectable changes in cell–cell adhesive strength are measur-
able. These and other data suggest that PV IgG binding to
Dsg3 is necessary, but not sufficient to disrupt KC adhesion
(Sato et al., 2000; Kitajima, 2002; Yamamoto et al., 2007;
Mao et al., 2009).
In the current study, a combination of biochemical and
imaging approaches was used to define the dynamics of the
PV IgG–Dsg3 complex during desmosome disassembly. The
results reveal that desmosome disassembly occurs in discrete
phases that proceed in a temporally predictable sequence.
These phases of disassembly include endocytosis of non-
desmosomal Dsg3 as previously demonstrated by Sato et al.
(2000) using immunogold electron microscopy. Internaliza-
tion of non-junctional Dsg3 is followed by the rearrangement
of desmosomal components into linear structures that appear
to function as sites for endocytosis of desmosomal pools
of Dsg3. This second phase is followed by depletion of
junctional Dsg3 and the loss of cell adhesion. Remarkably,
this process can be prevented by expressing exogenous Dsg3
to counteract this disassembly pathway with enhanced Dsg3
biosynthesis. These findings have important implications for
understanding the basic cellular mechanisms of desmosome
disassembly, and for designing therapeutic strategies to treat
PV and related disorders.
RESULTS
Time course of desmosome disassembly in response to PV IgG
In the current study, a series of biochemical and imaging
approaches were used to define the spatial and temporal
relationships between desmosomal components during des-
mosome disassembly in response to PV IgG. As shown in
Figure 1, PV IgG bind to KC intercellular junctions when cells
are incubated at 4 1C and colocalize with desmoplakin
along the cell borders (Figure 1a–c). After 1 hour at 37 1C,
PV IgG–Dsg3 complexes clustered into punctuate structures
that were distal to cell contacts and lacked desmoplakin
(Figure 1d–f). This pool of PV IgG–Dsg3 is likely to represent
internalization of Dsg3 from non-desmosomal compartments,
as previously described by Sato et al. (2000). This change in
Dsg3 distribution preceded disruption of desmoplakin
organization (Figure 1e). However, by 3–6 hours, desmopla-
kin was markedly disrupted and junctional Dsg3 localization
decreased (Figure 1g–l). By 24 hours, Dsg3 was largely
depleted, desmoplakin localization was highly disorganized
(Figure 1m–o), and cell–cell adhesion strength was signifi-
cantly compromised (Figure 8h and Calkins et al., 2006;
Delva et al., 2008). Control experiments using a monoclonal
antibody against Dsg3 confirmed that PV IgG colocalized
with Dsg3 over the 24 hours time course (Supplementary
Figure S1 online). To determine whether PV IgG-induced
desmosome rearrangement leads to depletion of desmosomal
components, KCs were incubated with NH (normal human)
or PV IgG for 24 hours. Sequential Triton X-100 detergent
extraction and western blot analysis was carried out to
determine whether membrane associated (Triton soluble) or
cytoskeleton associated (Triton insoluble) pools of desmoso-
mal proteins were depleted after 24 hours exposure to PV IgG
(Supplementary Figure S2 online). The Triton soluble pools of
desmoplakin, desmocollin-2 (Dsc2) and plakoglobin in PV
IgG-treated cells were similar to the NH control, whereas the
soluble pool of Dsg3 was dramatically reduced. The Triton
insoluble pools of desmoplakin and plakoglobin were not
altered by PV IgG. The insoluble pool of Dsc2 exhibited a
slight decrease in response to PV IgG, whereas Dsg3 levels
were considerably downregulated (see also Supplementary
Figure S4 online and Calkins et al., 2006). These data
demonstrate that morphological changes in Dsg3 are
followed by selective depletion of Dsg3 protein levels.
To further assess changes in the distribution of junction
components and overall cell shape, KCs were treated with
either NH IgG (Figure 2a–c) or PV IgG (Figure 2d–f) and the
localization of the adherens junction protein b-catenin was
used to outline cell–cell contacts. After 6 hours in PV IgG,
alterations in desmoplakin localization were observed, but
only minimal changes in b-catenin localization were
detected (Figure 2d and e). Furthermore, differential inter-
ference contrast microscopy demonstrated that PV IgG
treatment did not cause a dramatic alteration in cell shape
(Figure 2f). These data are consistent with previous findings
(de Bruin et al., 2007) and indicate that changes in
desmosomal protein distribution precede alterations in
adherens junctions and changes in cell shape.
Non-junctional Dsg3 is internalized and degraded before
desmosomes are disrupted by PV IgG
The results shown in Figure 1 suggest that the distribution of
desmosomal components is altered in a sequential manner
after exposure of KCs to PV IgG. To monitor sequential
changes in Dsg3 localization after addition of PV IgG, time-
lapse fluorescent-imaging experiments were conducted using
fluorescently tagged Dsg3 monoclonal antibodies (AK15 or
AK23; Tsunoda et al., 2003) to label cell surface pools of
Dsg3. To verify that these tracer antibodies did not cause
significant alterations in cell surface Dsg3 distribution, AK23
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was allowed to bind to KCs at 40C. Excess fluorescently
tagged AK23 was then removed from the medium and KCs
treated with either NH IgG or PV IgG for 6 hours at 37 1C
(Supplementary Figure S3 online). Note that very little change
in AK23 distribution was observed after 6 hours of exposure
to NH IgG, whereas the distribution of the AK23 complex
was dramatically altered by addition of PV IgG. Similar
results were obtained using AK15 (not shown). Therefore, a
series of experiments were conducted using fluorescently
tagged AK15 or AK23 monoclonal antibodies to monitor
Dsg3 distribution after exposure to PV IgG using four
dimensional time-lapse fluorescence microscopy of living
KCs. Over a time course of 4 hours, time-lapse imaging
demonstrated that Dsg3 is first clustered by PV IgG into
puncta, followed by rearrangement of junctional pools of
Dsg3 (Supplementary Movie S1 online). Additional time-
lapse imaging focusing on earlier time points revealed that
Dsg3 formed clusters on the dorsal surface of KCs (Figure
3a–d and Supplementary Movie S2 online). This clustering
occurred rapidly and preceded any obvious changes in Dsg3
at cell–cell borders. To determine the fate and composition of
these Dsg3 complexes, longer time-lapse imaging experi-
ments were conducted. In addition, the cells were fixed at the
end of the time-lapse series and processed for retrospective
immunofluorescence microscopy using antibodies directed
against early endosome antigen-1. This approach demon-
strated that clusters of Dsg3 formed within the first 2 hours
of PV IgG incubation at 37 1C (Figure 3e–g). Furthermore,
retrospective analysis revealed that many of the Dsg3 parti-
cles observed colocalize with early endosome antigen-1
(Figure 3h–i), demonstrating that Dsg3 is internalized.
Immunoblot analysis of Triton X-100 extracts of KCs
indicated that the soluble pool of Dsg3 is only slightly
diminished after incubation with PV IgG at these early time
points, and no consistent changes were observed in the
insoluble pool of Dsg3 (Figure 3j). Taken together, these
results suggest that the internalization of non-junctional pools
of Dsg3 occurs rapidly on exposure of KCs to pathogenic PV
IgG and that these changes precede alterations in the
junctional pools of Dsg3.
PV IgG cause rearrangement of cell surface Dsg3 into linear
arrays and subsequent internalization of Dsg3 from cell–cell
junctions
The data shown above indicate that internalization of non-
junctional Dsg3 precedes alterations in junctional pools of
Dsg3 and desmoplakin. Therefore, additional time-lapse
microscopy was carried out using fluorescently tagged
0 Hours
DP
PV lgG
Merge
1 Hour 3 Hours 6 Hours 24 Hours
Figure 1. Time course of desmosome disassembly in response to pemphigus vulgaris (PV) IgG. Keratinocytes (KCs) were exposed to PV IgG at 4 1C for
20minutes and subsequently shifted to 37 1C for 1, 3, 6, and 24 hours. The localization of human IgG and desmoplakin (DP) was monitored by
immunofluorescence microscopy. In cells incubated at 4 1C (a–c), PV IgG labels cell borders and desmoplakin staining is predominantly in punctate linear
patterns at cell–cell junctions. After 1 hour of treatment with PV IgG (d–f), the PV IgG–desmoglein-3 (Dsg3) molecules accumulate in puncta that are distal to
cell–cell borders, whereas desmoplakin (e) staining is unchanged. KCs treated with PV IgG for 3 and 6 hours exhibit a rearrangement of desmoplakin into linear
arrays emanating from cell borders, which contain both Dsg3 and desmoplakin. Following treatment with PV IgG for 24 hours (m–o) both Dsg3 and desmoplakin
are noticeably mislocalized and/or absent from cell–cell junctions. Bar¼10 mm.
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AK23 at later time points after addition of PV IgG. As shown
in Figure 4, over a time course of 2 hours, Dsg3 reorganizes
from the typical desmosomal pattern into linear arrays that
extend perpendicularly from cell borders (Figure 4a–c and
Supplementary Movie S3 online). Interestingly, the AK23–
Dsg3 complex appears to be released from the tips of these
linear arrays into vesicular structures that are transported in a
retrograde manner away from cell–cell junctions. Retro-
spective immunolocalization was used to define the compo-
sition of these linear arrays and vesicular structures.
AK23–Dsg3 complexes in linear arrays colocalized with
desmoplakin, whereas vesicular Dsg3 that is released from
the linear arrays did not (Figure 4d, see also Figure 5). These
findings suggest that the Dsg3–desmoplakin complex is
disrupted on Dsg3 endocytosis from the cell surface. To test
this possibility, cell surface Dsg3 was labeled with AK23 and
KCs were treated with PV IgG for 3 hours. The cells were then
transferred to 4 1C and either fixed immediately (Figure 4e) or
washed in a low-pH buffer before fixation to remove AK23
bound to the cell surface (Figure 4f; Delva et al., 2008).
Importantly, the low-pH wash removed AK23 that localized
to linear arrays, but the punctate AK23–Dsg3 particles
remained after the acid wash, indicating that this pool of
Dsg3 had been internalized. At this time point, soluble levels
of Dsg3 are notably reduced, whereas the Triton-X 100
insoluble pool of Dsg3 exhibits little or no change (Figure 4g).
These data suggest that the Dsg3 localized to linear arrays is
on the cell surface, whereas the vesicular structures released
from the linear arrays represent Dsg3 that has entered an
endocytic compartment.
To define the molecular composition of the Dsg3 linear
arrays, immunofluorescence microscopy was conducted on
KCs treated with PV IgG for 6 hours. Interestingly, the PV
IgG–Dsg3 complex in the linear arrays colocalized with all
desmosomal components tested, including desmoplakin
(Figure 5a–d), Dsc2 (Figure 5e–h), plakophilin-2 (Figure
5i–l), and plakoglobin (Figure 5m–p). However, PV IgG in
these linear arrays did not colocalize with the adherens
junction component E-cadherin (Figure 5q–t). The composi-
tion of these structures was analyzed further to determine
whether cytoskeletal elements were present in the linear
arrays. In KCs exposed to NH IgG, actin bundles were
prominent at cell–cell contacts (Figure 6a). As reported
previously (Berkowitz et al., 2005), exposure to PV IgG
resulted in retraction of actin bundles away from cell borders
(Figure 6d). In addition, actin filaments colocalized with
the PV IgG–Dsg3 complex that had reorganized into linear
arrays (Figure 6d–g). Keratin filaments also aligned with PV
NH IgG
β-cat
β-cat
PV IgG
DP
DP DIC
DIC
Figure 2. Desmosomes are disrupted by pemphigus vulgaris (PV) IgG but b-catenin is minimally affected and cells remain in close apposition. Keratinocytes
were treated with normal human (NH) IgG (a–c) or PV IgG (d–f) for 6 hours and subsequently processed for immunofluorescence. Note the robust b-catenin
(b-cat) and desmoplakin (DP) staining (a, b) in cells treated with NH IgG. The PV IgG-treated cells exhibit markedly disrupted desmoplakin staining at borders
(e), whereas b-catenin remains largely unaltered (d). Differential interference contrast (DIC) imaging shows that cells do not undergo major changes in cell shape
(f). Bar¼ 10mm.
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IgG in the linear arrays (Figure 6k–n). Together, these data
indicate that PV IgG causes reorganization of desmosomal
components into linear arrays that contain all of the
major desmosomal components, as well as actin and keratin
filaments.
A number of studies have implicated actin and actin
associated proteins in the regulation of desmosome assembly
(Godsel et al., 2005; Hatzfeld, 2007). The reorganization of
actin in response to pathogenic PV antibodies suggests that
the actin network may also be having a role in Dsg3
endocytosis and desmosome disassembly in PV IgG-treated
cells (Berkowitz et al., 2005). To test this possibility, KCs
were treated with latrunculin A to disrupt actin polymeriza-
tion. Interestingly, latrunculin A treatment resulted in
dramatically increased endocytosis of Dsg3 in PV IgG-treated
cells (Figure 7). Furthermore, time-lapse imaging revealed
that latrunculin A treatment eliminated the formation of the
typical linear arrays that form in PV IgG-treated cells
(compare Figure 7j–m, , and Supplementary Movies S4 and
S5 online). Instead, the PV IgG–Dsg3 complex was inter-
nalized in large aggregates directly from cell–cell contacts in
latrunculin A-treated cells. To investigate the role of actin in
PV IgG-induced Dsg3 downregulation, western blots were
performed on KCs incubated for 24 hours with NH or PV IgG,
with or without latrunculin A to inhibit actin polymerization
(Supplementary Figure S4 online). No changes in desmoso-
mal protein levels were observed in cells treated with NH IgG
and latrunculin A for 24 hours. However, both soluble and
insoluble pools of Dsg3 were reduced by PV IgG in the
absence and presence of latrunculin A. Interestingly, in cells
treated with both PV IgG and latrunculin A the Triton-X
soluble pools of Dsc2 and plakoglobin were modestly
AK 23
AK 23
AK 23 (R) and EEA-1 (G)
Soluble
Dsg3
Plakoglobin
0.5 Hours
Insoluble
NH PV NH PV
t = 0
t = 0 m t = 60 m t = 130 m
t = 120 seconds t = 400 seconds t = 550 seconds
Figure 3. Non-junctional pools of desmoglein-3 (Dsg3) are rapidly internalized after exposure to pemphigus vulgaris (PV) IgG. The Dsg3 antibody AK23 was
fluorescently tagged with Alexa Flour 555 and incubated with human keratinocytes for 30minutes at 4 1C. Unbound antibody was removed and media
containing PV IgG was added. Living cells were imaged using time-lapse fluorescence microscopy (a–d and e–g) to follow the dynamics of the Dsg3 complex in
PV IgG-treated cells. Note the appearance of AK23–Dsg3 clusters and vesicular structures that form rapidly after exposure to PV IgG, whereas junctional Dsg3
remains largely unaltered (Supplementary Movie S2 online). To determine the composition of the AK23–Dsg3 puncta (arrows, g), cells shown in panel G were
rapidly fixed and processed for indirect immunofluorescence using antibodies directed against early endosome antigen-1 (EEA-1). Note that the colocalization
between the AK23–Dsg3 complex and EEA-1 (arrows, h, i) indicates that the AK23–Dsg3 complex undergoes internalization to endosomes. Each panel in the
series represents a single-projection image of 7 (a–d) or 8 (e–g) z axis images collected at each time point. Sequential detergent extraction and western blot
analysis were carried out to determine whether membrane-associated (Triton X-100 soluble) or cytoskeleton-associated (Triton X-100 insoluble) pools of Dsg3
were depleted. A decrease in the soluble pool of Dsg3 was detected within 30minutes of incubation with PV IgG (j). Results are representative of at least three
independently conducted experiments. NH, normal human. Bar¼10 mm.
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decreased. Furthermore, the insoluble pools of desmoplakin,
Dsc2, and plakoglobin were reduced similarly to Dsg3.
Together, these data indicate that PV IgG and actin depoly-
merization act synergistically to decrease steady state
desmosomal protein levels.
Expression of exogenous Dsg3 prevents desmosome disassembly
and loss of adhesion
The rearrangement of Dsg3 into linear arrays followed by
release of Dsg3 into vesicular structures precedes the
dramatic loss of Dsg3 and desmoplakin from cell–cell borders
that are observed by 24 hours (Figure 1m–o). By 24 hours,
both the Triton soluble and insoluble pools of Dsg3 are
depleted (Figure 8a, Supplementary Figures S2 and S4
online). Recently, we reported that Dsg3 is internalized
through a clathrin- and dynamin-independent mechanism
in PV IgG-treated KCs (Delva et al., 2008). Therefore,
we hypothesized that the disruption of desmosomes and the
loss of adhesion in response to PV IgG is caused by the
internalization of both non-junctional and junctional pools of
Dsg3, leading to depletion of cell surface Dsg3 and the loss of
adhesion. Therefore, we reasoned that the loss of adhesion in
PV IgG-treated cells might be prevented by enhancing Dsg3
biosynthesis rates to counter the increase in Dsg3 endocytosis
and turnover. To test this possibility, a green fluorescent
protein (GFP)-tagged Dsg3 fusion protein (Dsg3.GFP) was
expressed exogenously using an adenoviral delivery system.
As shown in Figure 8a, PV IgG treatment for 24 hours
results in decreased Dsg3 levels in both the Triton soluble
and insoluble pools. Importantly, expression of exogenous
Dsg3.GFP prevented the downregulation of Dsg3 levels in
PV IgG-treated KCs. To determine whether expression of
exogenous Dsg3.GFP could also prevent alterations in
desmoplakin localization in PV IgG-treated cells, Dsg3.GFP
was expressed in NH IgG- (Figure 8b–d) and PV IgG- (Figure
8e–g) treated KCs. Interestingly, expression of Dsg3.GFP
prevented the disruption of desmoplakin organization in PV
IgG-treated KCs (Figure 8e–g). Note that cells expressing
Dsg3.GFP exhibit well-organized desmoplakin staining at
cell borders, whereas desmoplakin staining is dramatically
reduced in adjacent cells lacking exogenous Dsg3 expres-
sion. These data suggested that exogenous expression of Dsg3
may prevent the loss of adhesion triggered by PV IgG.
Remarkably, expression of exogenous Dsg3.GFP reduced the
number of fragments generated in PV IgG-treated KCs
exposed to mechanical stress (Figure 8h). Together, these
findings indicate that exogenous expression of Dsg3 prevents
the downregulation of total cellular Dsg3 protein levels, the
(AK23 Dsg 3)
t = 0 m
AK 23
Soluble Insoluble
Dsg3
Plakoglobin
6 Hours
PVNHNH PV
AK 23 acid wash
t = 60 m t = 120 m AK23 (R) and DP (G)
Figure 4. The pemphigus vulgaris (PV) IgG–desmoglein-3 (Dsg3) complex reorganizes into linear arrays that exhibit retrograde movement before entering
vesicular compartments. Keratinocytes (KCs) were incubated at 4 1C with Alexa Flour labeled AK23 monoclonal antibody for 30minutes. Unbound antibody
was removed followed by the addition of KC media containing PV IgG. Cells were then imaged every 5minutes for 2 hours at 37 1C. Notice the formation of
linear arrays of AK23–Dsg3, followed by apparent budding of vesicular structures from the tips of the arrays (b, c) (Supplementary Movie S3 online).
Retrospective immunofluorescence analysis (d) indicates that Dsg3 that has entered this vesicular compartment is no longer associated with desmoplakin
(arrows, d). To determine whether Dsg3 in the linear arrays was present on the cell surface, living cells were incubated with the pathogenic monoclonal AK23
for 3 hours in the presence of PV IgG. Cells were then incubated on ice and either fixed immediately (e) or incubated in a low-pH acid wash before fixation
(f) to remove cell surface bound AK23 IgG. Note that the linear arrays are not observed in cells exposed to the low-pH wash, demonstrating that Dsg3 in these
structures is present at the cell surface and that the punctate vesicular Dsg3 observed in (f) is intracellular. Western blot analysis of KC lysates treated for
6 hours in PV IgG reveals a decrease in the non-junctional Triton X-100 soluble pool of Dsg3, whereas the Triton insoluble pool of Dsg3 exhibited little or no
change. No changes in plakoglobin levels were observed (g). Results are representative of at least three independently conducted experiments.
DP, desmoplakin; NH, normal human. Bar¼ 10mm.
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PV IgG DP Merge
Dsc2PV IgG
PV IgG Pkp-2
EcadPV IgG
PV IgG PG
Figure 5. Linear arrays contain desmosomal but not adherens junction components. Primary human keratinocytes were incubated with pemphigus
vulgaris (PV) IgG for 6 hours and then processed for confocal immunofluorescence microscopy for PV IgG and either desmoplakin (DP, a–d), desmocollin-2
(Dsc2, e–h), plakophilin-2 (Pkp-2, i–l), plakoglobin (PG, m–p), or E-cadherin (Ecad, q–t). Note that the PV IgG complex colocalizes with each of the
desmosomal components in linear arrays, but does not colocalize with the adherens junction marker E-cadherin (arrows, t). Bar¼ 10mm.
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disruption of desmoplakin localization, and the loss of
adhesion strength in response to PV IgG.
DISCUSSION
The results of this study indicate that desmosome disassembly
in response to PV IgG occurs in three sequential, but
temporally overlapping phases. Time-lapse fluorescence
microscopy indicates that the first phase of PV IgG-induced
disassembly (phase 1) is characterized by endocytosis of the
non-junctional pool of Dsg3 (Figures 1 and 3). These findings
are consistent with previous studies using immunogold
electron microscopy and time-lapse labeling (Sato et al.,
2000). The internalized Dsg3 is then delivered to early
endosomes (Figure 3), where it is most likely sorted for
degradation in lysosomes (Calkins et al., 2006). This model is
supported by the observation that the internalization of Dsg3
is accompanied by a decrease in the Triton soluble pool of
Dsg3 as assessed biochemically (Figure 3j). In contrast,
junctional pools of Dsg3 are largely unaffected over the
course of the first 1–2 hours after PV IgG binding to the KC
Actin
Actin
NH IgG
PV IgG Merge
Merge
Merge
NH IgG
PV IgG
Keratin
Keratin
Merge
Figure 6. Pemphigus vulgaris (PV) IgG–desmoglein-3 in linear arrays colocalize actin and align with keratin filaments. Keratinocytes were treated with
either normal human (NH) IgG or PV IgG for 6 hours and processed for immunofluorescence localization of NH and PV IgG with actin (a–g) or NH and PV IgG
with cytokeratin (h–n). Note colocalization of PV IgG in linear arrays with actin, which emanate away from cell–cell borders in alignment with keratin filaments.
Panels g and n represent higher magnification views of insets shown in panels f and m, respectively. Images shown are single z-plane representations that were
captured using wide field microscopy followed by deconvolution. Bar¼ 20 mm.
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cell surface (Figure 1d–f). Furthermore, there is no significant
loss of adhesive strength at these early time points (Calkins
et al., 2006), consistent with the observation that the
desmosomal pool of Dsg3 remains intact even while the
non-desmosomal pool decreases. Thus, the non-desmosomal
pool of Dsg3 is most susceptible to the effects of pathogenic
antibody binding, and internalization of this pool from the
cell surface occurs during the first phase of desmosome
disassembly in response to PV IgG.
A prominent feature of KCs treated for 2–6 hours with
PV IgG (phase 2) is the rearrangement of desmosomal
components into linear arrays, which align with keratin
filaments and extend away from cell–cell borders (Figures 5
and 6). The linear arrays colocalize with actin and contain
not only the PV IgG–Dsg3 complex, but also all other
desmosomal components examined (Figures 5 and 6).
Importantly, the Dsg3 complex appears to emerge from the
tips of these arrays into vesicular structures that are
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Figure 7. Actin depolymerization increases pemphigus vulgaris (PV) IgG-induced desmoglein-3 (Dsg3) internalization. Keratinocytes (KCs) were untreated
(a,b and e,f) or treated with latrunculin A (250 nM; c,d and g,h) at 37 1C for 1 hour. Cells were then incubated at 4 1C for 30minutes with AK23 IgG to label
cell surface pools of Dsg3. Excess AK23 antibody was removed from the medium, NH (normal human) IgG or PV IgG were added, and the cells were shifted to
37 1C for 3 hours. To visualize only the intracellular pool of Dsg3, cells were washed in a low pH buffer at 4 1C to remove surface bound antibody before
processing for immunofluorescence. Bar¼ 5mm. The amount of internalized AK23–Dsg3 was then quantified (i). Error bars represent the SE of the mean,
where n¼ 15 fields of view. In parallel experiments, time-lapse microscopy was used to visualize Dsg3 dynamics in PV IgG- (j–m) or PV IgG þ latrunculin
A- (o–r) treated KCs (Supplementary Movies S4 and S5 online). DAPI, 4’-6-diamidino-2-phenylindole.
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Figure 8. Expression of exogenous desmoglein-3 (Dsg3).GFP prevents desmoplakin mislocalization and loss of cell adhesion in pemphigus vulgaris (PV)
IgG-treated keratinocytes. Dsg3.GFP was expressed in keratinocytes (KCs) using an adenoviral delivery system 24 hours before treatment with normal human
(NH) or PV IgG. After an additional 24 hours, cells were processed for sequential detergent extraction and western blot (a), immunofluorescence (b–g), or
subjected to mechanical stress to measure cell adhesion strength (h). Note that expression of exogenous Dsg3.GFP prevented the downregulation of Dsg3 in
both the Triton X-100 soluble and insoluble pools in PV IgG (P)-treated cells compared with cells treated with NH IgG (N) (a). Note that Dsg3.GFP colocalized
with desmoplakin in NH IgG-treated cells (b–d) and prevented mislocalization of desmoplakin in PV IgG-treated cells (e–g). Note also the robust desmoplakin
staining in cells that are expressing Dsg3.GFP (arrows, g) in sharp contrast to adjacent cells lacking Dsg3.GFP (arrowheads, g). To determine whether Dsg3.GFP
expression could prevent loss of cell adhesion strength in PV IgG-treated cells, NH IgG- or PV IgG-treated KCs were released from the substrate using the
enzyme dispase and subjected to mechanical stress. The number of resulting monolayer fragments was quantified. Note that exogenous Dsg3.GFP rendered PV
IgG-treated KCs resistant to mechanical stress. The graph represents an average of three separate experiments quantified by a blinded observer. PV IgG-treated
KCs expressing Dsg3.GFP exhibited significantly less fragments than those expressing empty adenovirus as determined using analysis of variance with post hoc
least significant difference analysis (**Po0.01). Error bars represent the SD. GFP, green fluorescent protein. Bar¼ 10mm.
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internalized (Figure 4). At these intermediate time points,
adherens junction components are well organized and cells
remained closely apposed (Figure 2). These data indicate that
alterations in desmosomal organization precede changes in
adherens junctions and alterations in cell shape. Finally, phase
3 of disassembly (6–24hours) is characterized by disruption of
desmosomal components and loss of adhesion strength. At
these later time points, the depletion of Dsg3 from both the
soluble and insoluble pools was dramatic (Figures 1m–o, 8 and
Supplementary Figures S2 and S4 online).
Previous studies using time-lapse imaging of desmosome
assembly revealed that desmosome formation also takes
place in discrete phases (Godsel et al., 2005; Bass-Zubek
et al., 2008). In these studies, desmoplakin and the
desmosomal cadherins appear to form distinct complexes
during assembly and are transported separately to sites of
junction formation. This process appears analogous to that
observed during disassembly. For example, Dsg3 colocalizes
extensively with plakoglobin on internalization. However,
none of the other desmosomal components examined,
including plakophilin-2 and desmoplakin, colocalize with
the internalized pool of Dsg3 (Calkins et al., 2006).
Cytoskeletal elements are also involved in desmosomal
assembly and disassembly. Cytochalasin D disrupts actin
filaments and impairs desmosome assembly, implicating
the actin cytoskeletal network in the process of desmo-
some formation (Godsel et al., 2005). Similarly, we observed
colocalization between the actin cytoskeleton and the linear
arrays that characterize phase 2 of disassembly in response to
PV IgG (Figure 6). In addition, disruption of actin polymer-
ization caused a dramatic increase in Dsg3 endocytosis from
both the cell surface and from intercellular junctions
(Figure 7), consistent with a recent report suggesting that
the actin cytoskeleton regulates desmosome disassembly in
response to PV IgG (Gliem et al., 2010). These data suggest
that actin has roles in both assembly and disassembly of
desmosomes, and that desmosomal protein association with
the actin cytoskeleton may be most prominent and function-
ally relevant when desmosomal components are undergoing
dynamic regulation.
A key issue in pemphigus pathophysiology is the
mechanism by which PV IgG binding to Dsg3 causes loss
of adhesion. The data presented here, along with a number of
other studies, suggest that PV IgG binding to Dsg3 is
insufficient to cause loss of KC adhesion (Muller et al.,
2008; Waschke, 2008). Rather, it appears that PV IgG binding
disrupts the kinetics of assembly and disassembly by favoring
endocytosis of Dsg3 and alterations in desmosome organiza-
tion that lead to disassembly. A prediction based on this
hypothesis is that increasing Dsg3 biosynthesis should
counteract the increase in Dsg3 endocytosis and turnover
caused by PV IgG. As shown in Figure 8, expression of
exogenous Dsg3 using an adenoviral delivery system
prevented the downregulation of Dsg3, disruption of desmo-
plakin organization, and loss of adhesion in PV IgG-treated
cells. These findings suggest that induction of endocy-
tosis and turnover of Dsg3 causes loss of adhesion, and
that increased Dsg3 biosynthesis is sufficient to restore
desmosome assembly and adhesion. The precise mechanism
by which expression of exogenous Dsg3 prevents loss of
adhesion is not fully understood, and may involve upregula-
tion of other adhesion molecules or desmosomal plaque
proteins. Interestingly, we find that KCs become more
resistant to the effects of PV IgG on adhesion with increasing
time in high-calcium medium (Saito and Kowalczyk,
unpublished). This increased resistance to PV IgG is most
likely due to increased Dsg3 cell surface levels and decreased
Dsg3 endocytosis when cells are cultured in high calcium
(Delva and Kowalczyk, 2009). These findings suggest that
treatment of pemphigus patients with agents that enhance
Dsg3 biosynthesis or stabilize desmosomes may be bene-
ficial. Consistent with this notion, corticosteroids have been
found to increase Dsg3 transcription (Nguyen et al., 2004).
Along with the results present here, these findings suggest that
corticosteroids may be beneficial in pemphigus treatment due
to increase expression of adhesion molecules in addition to
immune suppression.
MATERIALS AND METHODS
Cell culture
Primary human KCs were isolated from neonatal foreskin and cultured
in KC growth medium (Cascade Medium 154 or Gibco Defined
Keratinocyte-SFM, Invitrogen, Carlsblad, CA) as described previously
(Calkins et al., 2006; Delva et al., 2008). KCs, no later than passage 3,
were then switched into media containing 0.55mM or 1.2mM calcium
for 16–18hours before experimental manipulations.
Immunofluorescence
KCs were seeded onto glass coverslips and allowed to proliferate to
desired confluence. Cells were switched to 0.55mM calcium-
containing media for 16–18 hours before treatment with NH IgG
(Invitrogen) or PV IgG for varying amounts of time. Sera from PV
patients were acquired without identifiers and IgG was affinity
purified as previously described (Calkins et al., 2006; Delva et al.,
2008). Data shown are representative of at least two different PV
patient IgG and/or pathogenic monoclonal Dsg3 antibodies (Tsuno-
da et al., 2003). NH IgG or PV IgG was added to cell culture media
at 100–150 mgml1 and allowed to bind to KC cell surfaces at 4 1C
for 30minutes before incubation at 37 1C. On completion of the
incubation at 37 1C, cells were washed three times with phosphate-
buffered saline (PBS)þ , and then fixed on ice using either 20 1C
methanol for 2–4minutes or 4.0% paraformaldehyde (Electron
Microscopy Sciences, Hatfield, PA) for 10minutes followed by
extraction with 0.1% Triton X-100 (Roche Diagnostics, Indianapolis,
IN) for 7minutes. The localization of desmosomal components was
assessed using the following antibodies: rabbit anti-desmoplakin
(GeneTex, San Antonio, TX), rabbit anti-desmoplakin (NW6 a gift
from Dr Kathleen Green, Northwestern University), mouse anti-
desmoplakin (Fitzgerald Industries International, Concord, MA.),
mouse anti-plakoglobin (BD Transduction Laboratories), mouse
anti-desmocollin-2 (7G6, a gift from Dr James Wahl), mouse anti-
plakophillin-2 (Meridian Life Sciences, Saco, ME), rabbit anti-
b-catenin (Lab Vision Products, Thermo Fisher Scientific, Fremont,
CA), mouse anti-E-cadherin (BD Transduction Laboratories), and
mouse anti-cytokeratin (Immunotech, Marseille, France). Secondary
antibodies to appropriate species conjugated to various Alexa Fluors
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(Invitrogen) were used for dual-label staining. Localization of actin
was monitored using Alexa Fluor 555 phalloidin (Invitrogen).
Endocytosis of Dsg3 was quantified by measuring fluorescence
intensity of intracellular AK23/Dsg3 using a low-pH wash to remove
cell surface antibody as previously described (Delva et al., 2008).
Latrunculin A (Invitrogen) was used at 250 nM.
Time-lapse microscopy
Immunofluorescence analysis and time-lapse microscopy were
carried out using an inverted Leica DMI-6000B microscope (Leica,
Wetzlar, Germany) equipped for wide field and confocal micro-
scopy. Confocal microscopy was carried out using two solid-state
lasers (491 and 561 nm) and a VT Infinity 2D array scanner (VisiTech
International, Sunderland, UK). Images were captured using a
Hamamatsu electron multiplier deep cooled CCD camera (C9100-
12). An automated stage and image acquisition were driven by
Simple PCI software (Hamamatsu Corporation, Sewickley, PA). For
live-cell analysis, temperature control was achieved using an
environmental control chamber (Pecon Incubator ML) and heated
stage insert (Pecon Heating Insert P). For time-lapse experiments,
KCs were seeded into chamber slides (Lab-Tek/Nunc, Rochester,
NY) and then switched to medium containing 0.55mM calcium for
16–18hours before the launch of the experiment. KCs were placed
on ice and labeled with Alexa Flour 555-tagged AK23 or AK15
monoclonal antibodies directed against Dsg3 (Tsunoda et al., 2003)
for 20–30minutes. Unbound AK23 or AK15 antibody was removed
using a PBSþ wash and fresh media containing PV IgG was added
and then to the cells were warmed to 37 1C. Time-lapse images and
movies represent projection images of the entire cell z-plane of the
cell. Retrospective analysis was achieved by removing the cells from
the microscope chamber, immediately fixing in 4.0% paraformalde-
hyde (Electron Microscopy Sciences) for 10minutes followed by
0.1% Triton X-100 (Roche Diagnostics) extraction and staining with
appropriate primary antibody. On completion of staining, fixed KCs
were placed back on the microscope in the exact location where
time-lapse imaging occurred.
Sequential detergent extraction and western blot analysis
For western blot analysis, KCs were grown in 35mm or 4-well tissue
culture plates and extracted sequentially in Triton buffer (1% Triton
X-100, 10mM Tris, pH 7.5, 140mM NaCl, 5mM EDTA, 2mM EGTA,
with protease inhibitor cocktail tablets from Roche Diagnostics)
followed by extraction with urea–SDS buffer (1% SDS, 8 M urea,
10mM Tris-HCL, pH 7.5, 5mM EDTA, 2mM EGTA) as described
previously (Calkins et al., 2006). Rabbit anti-Glyceraldehyde
3-phosphate dehydrogenaseA (GAPDH, Santa Cruz, Santa Cruz, CA),
mouse anti-cytokeratin and anti-plakoglobin (mentioned above) were
used as loading controls for the Triton soluble and insoluble fractions.
Horseradish peroxidase-conjugated secondary antibodies (BioRad,
Hercules, CA) were detected using enhanced chemiluminescence
(GE Healthcare, Little Chalfont, Buckinghamshire, UK).
Dispase cell dissociation assay
KCs were grown to 100% confluence in 35mm tissue culture plates.
Cells were switched into 1.2mM calcium-containing media 16–18hours
before the addition of NH or PV IgG at B100mgml1. After 24hours,
KCs were washed with PBSþ and incubated with 1Uml1 dispase
(Roche Diagnostics) for 30minutes to an hour. Following release from
the culture plate, the cell sheets were transferred to 15-ml conical tubes
containing 11ml final volume of PBSþ and subjected to mechanical
stress by 50 inversion cycles on a rocker panel. Fragments were counted
using a dissecting microscope. Adenovirus expressing Dsg3.GFP or
empty vector adenovirus (GFP alone) was added to cells 24hours before
the addition of PV IgG or NH IgG.
Adenovirus expression
A full-length GFP-tagged Dsg3 adenoviral expression constructed
was generated as follows. The cDNA encoding mouse Dsg3 was
subcloned into pEGFP-N1 (Clontech, Mountain View, CA). GFP
tagged Dsg3 (Dsg3.GFP) was further subcloned into pENTR11 vector
(Invitrogen). A pAd-CMV-Dsg3.GFP expression vector was then
generated with pENTR11-Dsg3.GFP using the Gateway system. PacI
digested pAd-CMV-Dsg3.GFP was transfected into 293 cells and
recombinant Dsg3.GFP adenovirus was generated and purified as
described previously (Delva et al., 2008).
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